Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.

Eri KoshiShoji SaitoMasaki OkazakiYuki ToyamaTakuji IshimotoTomoki KosugiHiroaki HiraiwaNaruhiro JingushiTakanori YamamotoMasayuki OzakiYukari GotoAtsushi NumaguchiYasuhiro MiyagawaIo KatoNobuyuki TetsukaTetsuya YagiShoichi Maruyama

Published in: CEN case reports (2020)

Favipiravir may be an effective option for the treatment of COVID-19-infected patients with ESRD.

Keyphrases

end stage renal disease
coronavirus disease
chronic kidney disease
peritoneal dialysis
sars cov
respiratory syndrome coronavirus
case report
combination therapy
replacement therapy